The Filing Desk

Mannatech vs Solesence

Mannatech MTEX · Solesence SLSN · Personal Care Products

Mannatech reported revenue of $108 million in fiscal 2025, 1.7 times Solesence's $62 million in fiscal 2025. Mannatech's revenue fell 8.3% in its latest year, and Solesence's grew 18.6%. Mannatech had an operating margin of -0.4%, against 4.2% at Solesence.

Side by side

MannatechSolesence
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$108M$62M
Revenue growth−8.3%18.6%
Revenue growth a year, last 5 years−6.5%29.4%
Gross margin74.9%27.5%
Operating margin−0.4%4.2%
Net margin−14.1%4.5%
Free cash flow−$4M—
Free cash flow margin−4.0%—
Return on capital——
Net debt to EBITDA−4.1x—
Dividends and buybacks$0M$0M
Change in diluted share count0.8%11.6%
Last close$2.45$1.48
P/E at the last close—29.6×
Insider trades, last 12 months—bought $4,785, sold $0
Piotroski F-score2 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
MannatechSolesence
Operating margin
Percent of revenue
MannatechSolesence
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
MannatechSolesence

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Mannatech and Solesence pages.